  |
High-dose vitamin C reduces inflammation in cancer patients, study shows |
|
High-dose vitamin C reduces inflammation in cancer patients, study shows
|
Darrell Miller | 12/07/16 |
Date:
December 07, 2016 04:59 PM
Author: Darrell Miller
(support@vitanetonline.com)
Subject: High-dose vitamin C reduces inflammation in cancer patients, study shows
It is was the first time this type of treatment was tested and studied specifically for its effects on inflammation in cancer patients. The results found indicate great promise for the use of high-dose intravenous vitamin C treatments to help reduce inflammation in cancer patients, which is one of the major factors of cancer and its progression. A range of cancers has been proven to benefit from vitamin C treatments, including cancers of the prostate, breast, skin, bladder, lung, pancreas, thyroid, and B-cell lymphoma.
Key Takeaways:
- Now, another study is confirming its effectiveness against inflammation in cancer patients, one of the primary markers.
- High levels of inflammation seem to indicate a higher risk of cancer as well as a less hopeful prognosis for healing and recovery.
- The current amount of inflammation in the body can actually predict the chances and length of survival time for numerous types of cancer.
"High levels of inflammation seem to indicate a higher risk of cancer as well as a less hopeful prognosis for healing and recovery."
Reference:
